Emergent BioSolutions (EBS) Raw Materials (2011 - 2018)

Emergent BioSolutions has reported Raw Materials for 8 years, with the latest figure at $51.8 million in Q4 2018.

• On a quarterly basis, Raw Materials rose 43.49% year-over-year to $51.8 million in Q4 2018; TTM through Dec 2018 was $51.8 million, a 43.49% increase from a year earlier, with the FY2018 full-year figure at $51.8 million, up 43.49% from the prior year.
• Raw Materials was $51.8 million for Q4 2018 at Emergent BioSolutions, up from $33.8 million in the prior quarter.
• The five-year high for Raw Materials was $51.8 million in Q4 2018, with the low at $15.0 million in Q2 2014.
• Average Raw Materials over 5 years is $27.5 million, with a median of $29.3 million recorded in 2016.
• The sharpest annual moves came in 2014 and 2015: Raw Materials surged 614.81% in 2014, then retreated 7.19% in 2015.
• Over 5 years, Raw Materials stood at $17.4 million in 2014, then grew by 22.45% to $21.3 million in 2015, then jumped by 44.24% to $30.7 million in 2016, then grew by 17.64% to $36.1 million in 2017, then surged by 43.49% to $51.8 million in 2018.
• The last three Raw Materials figures came in at $51.8 million (Q4 2018), $33.8 million (Q3 2018), and $34.4 million (Q2 2018), per Business Quant data.